14159, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 489,746 shares at $64.62 ($32.3M) on 2019-04-12, disclosed to the SEC on 2019-04-12.
Open-market sale of $32.3M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.61 | 106,054 | $7.1M | 21.9% |
| 2 | $66.61 | 124 | $8K | 0.0% |
| 3 | $66.61 | 1,628 | $108K | 0.3% |
| 4 | $66.61 | 1,817 | $121K | 0.4% |
| 5 | $66.61 | 2,807 | $187K | 0.6% |
| 6 | $66.61 | 16,282 |
| $1.1M |
| 3.4% |
| 7 | $67.42 | 71 | $5K | 0.0% |
| 8 | $67.42 | 60,618 | $4.1M | 12.7% |
| 9 | $67.42 | 930 | $63K | 0.2% |
| 10 | $67.42 | 1,039 | $70K | 0.2% |
| 11 | $67.42 | 1,604 | $108K | 0.3% |
| 12 | $67.42 | 9,307 | $627K | 1.9% |
| 13 | $64.62 | 173,085 | $11.2M | 34.6% |
| 14 | $64.62 | 202 | $13K | 0.0% |
| 15 | $64.62 | 2,656 | $172K | 0.5% |
| 16 | $64.62 | 2,966 | $192K | 0.6% |
| 17 | $64.62 | 4,581 | $296K | 0.9% |
| 18 | $64.62 | 26,575 | $1.7M | 5.3% |
| 19 | $67.13 | 74 | $5K | 0.0% |
| 20 | $67.13 | 63,775 | $4.3M | 13.3% |
| 21 | $67.13 | 979 | $66K | 0.2% |
| 22 | $67.13 | 1,093 | $73K | 0.2% |
| 23 | $67.13 | 1,688 | $113K | 0.4% |
| 24 | $67.13 | 9,791 | $657K | 2.0% |
| Total | $65.96 avg | 489,746 | $32.3M | 100% |
| Filing → |
| ACAD | BUY | 2018-12-04 | $200.0M | — | Filing → |
| GHDX | SELL | 2018-12-03 | $15.9M | — | Filing → |
| GHDX | SELL | 2018-11-13 | $6.6M | — | Filing → |